Qi, Y.A.; Maity, T.K.; Gao, S.; Gong, T.; Bahta, M.; Venugopalan, A.; Zhang, X.; Guha, U.
Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma. Cancers 2021, 13, 4977.
https://doi.org/10.3390/cancers13194977
AMA Style
Qi YA, Maity TK, Gao S, Gong T, Bahta M, Venugopalan A, Zhang X, Guha U.
Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma. Cancers. 2021; 13(19):4977.
https://doi.org/10.3390/cancers13194977
Chicago/Turabian Style
Qi, Yue A., Tapan K. Maity, Shaojian Gao, Tao Gong, Meriam Bahta, Abhilash Venugopalan, Xu Zhang, and Udayan Guha.
2021. "Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma" Cancers 13, no. 19: 4977.
https://doi.org/10.3390/cancers13194977
APA Style
Qi, Y. A., Maity, T. K., Gao, S., Gong, T., Bahta, M., Venugopalan, A., Zhang, X., & Guha, U.
(2021). Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma. Cancers, 13(19), 4977.
https://doi.org/10.3390/cancers13194977